Results 11 to 20 of about 96,164 (192)
Role of Leptin in Non-Alcoholic Fatty Liver Disease
Biomedicines, 2021 Non-alcoholic fatty liver disease (NAFLD), which affects about a quarter of the global population, poses a substantial health and economic burden in all countries, yet there is no approved pharmacotherapy to treat this entity, nor well-established ...
Carlos Jiménez-Cortegana +7 more
doaj +1 more source
Molecules, 2020 Overfeeding of a hypercaloric diet leads to obesity, diabetes, chronic inflammation, and fatty liver disease. Although limiting fat or carbohydrate intake is the cornerstone for obesity management, whether lowering fat or reducing carbohydrate intake is ...
Caíque S. M. Fonseca +6 more
doaj +1 more source
Nonalcoholic Steatohepatitis [PDF]
Mayo Clinic Proceedings, 2000 Nonalcoholic steatohepatitis (NASH) is a liver disease that, until recently, has been underrecognized as a common cause of elevated liver enzymes. This distinct clinical entity is characterized by liver biopsy findings similar to those seen in alcoholic hepatitis but in the absence of alcohol consumption sufficient to cause such changes.
K S, Kumar, P F, Malet
openaire +2 more sources
Beneficial Effects of Opuntia spp. on Liver Health
Antioxidants, 2023 The genus Opuntia spp. includes plants capable of growing in arid, temperate and tropical climates. The vast majority of wild species grow in Mexico, but O.
Irene Besné-Eseverri +5 more
doaj +1 more source
Omalizumab-Associated Steatohepatitis
Actas Dermo-Sifiliográficas, 2023 Article disponible en castellà: http://hdl.handle.net/10230 ...
Barbosa, Joana +3 more
openaire +5 more sources
Gastroenterology Insights, 2023 Hepatitis C infection is a leading etiology of hepatic dysfunction and a major indication for liver transplantation due to the development of fibrosis, cirrhosis, and hepatocellular carcinoma.
Sonia Samuel, Ahmad Abulawi, Raza Malik
doaj +1 more source
Frontiers in Cell and Developmental Biology, 2023 In recent years, there has been a rapid expansion in our understanding of regulated cell death, leading to the discovery of novel mechanisms that govern diverse cell death pathways.
Christian Stoess +4 more
doaj +1 more source
Best Practice & Research Clinical Gastroenterology, 2002 Pathologists have long been involved in clinical diagnosis and investigative studies of various forms of liver disease, including alcoholic liver disease. The concept that progressive fatty liver disease may result from causes other than alcohol toxicity can be noted in the literature.
Brunt, EM, Tiniakos, DG
openaire +3 more sources
Non-alcoholic fatty liver disease: Definition and subtypes [PDF]
Clinical and Molecular Hepatology, 2023 Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases worldwide, with a global prevalence of approximately 30%. However, the prevalence of NAFLD has been variously reported depending on the comorbidities.
Seul Ki Han +2 more
doaj +1 more source
Frontiers in Endocrinology, 2022 BackgroundNon-alcoholic fatty liver disease (NAFLD), a metabolic disorder that develops from non-alcoholic fatty liver (NAFL) to non-alcoholic steatohepatitis (NASH), has become an epidemic of chronic liver dysfunction worldwide. However, mechanisms that
Xiaoya Li +10 more
doaj +1 more source